Characterisation of protein microheterogeneity and protein complexes using on-chip immunoaffinity purification-mass spectrometry

Briefings in Functional Genomics and Proteomics

Volumn 4, Issue 1, 2005, Pages 7-15

  Schweigert, Florian J ^a  

^a UNIVERSITY OF POTSDAM   (Germany)

Author keywords

Biomarker; Heteromics; Immunoassays; Interactomics; Mass spectrometry; Microheterogeneity; Protein complexes

Indexed keywords

PLASMA PROTEIN; PREALBUMIN; RETINOL BINDING PROTEIN;

AMYLOIDOSIS; ANTIBODY AFFINITY; COMPLEX FORMATION; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; KIDNEY DISEASE; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; NUTRITIONAL DISORDER; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN POLYMORPHISM; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN TRANSPORT; PROTEOMICS; RECEPTOR BINDING; REVIEW; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

AMYLOID; BLOTTING, WESTERN; HUMANS; IMMUNOASSAY; MASS SPECTROMETRY; PREALBUMIN; PROTEIN ARRAY ANALYSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; PROTEOMICS; RETINOL-BINDING PROTEINS;

EID: 19444386321     PISSN: 14739550     EISSN: None     Source Type: Journal    
DOI: 10.1093/bfgp/4.1.7     Document Type: Review

References (62)

1. Haynes, P., Miller, I., Aebersold, R. et al. (1998), 'Proteins of rat serum: I. Establishing a reference two-dimensional electrophoresis map by immunodetection and microbore high performance liquid chromatography-electrospray mass spectrometry', Electrophoresis, Vol. 19, pp. 1484-1492.
2. Hochstrasser, D. F., Sanchez, J. C. and Appel, R. D. (2002), 'Proteomics and its trends facing nature's complexity', Proteomics, Vol. 2, pp. 807-812.
3. Molloy, M. P. and Witzmann, F. A. (2002), 'Proteomics: technologies and applications', Brief. Funct. Genomic. Proteomic., Vol. 1, pp.23-39.
4. Tyers, M. and Mann, M. (2003), 'From genomics to proteomics', Nature, Vol. 422, pp. 193-197.
5. Apweiler, R., Hermjakob, H. and Sharon, N. (1999), 'On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database', Biochim. Biophys. Acta, Vol. 1473, pp. 4-8.
6. Banks, R. E., Dunn, M. J., Hochstrasser, D. F. et al. (2000), 'Proteomics: New perspectives, new biomedical opportunities', Lancet, Vol. 356, pp. 1749-1756.
7. Baumann, M. and Meri, S. (2004), 'Techniques for studying protein heterogeneity and post-translational modifications', Expert Rev. Proteomics, Vol. 1, pp. 207-217.
8. Davis, B. G. (2004), 'Biochemistry. Mimicking posttranslational modifications of proteins', Science, Vol. 303, pp. 480-482.
9. Hancock, W. S. (2002), 'Glycosylation, who cares?',J. Proteome Res., Vol. 1, p. 297.
10. Mann, M. and Jensen, O. N. (2003), 'Proteomic analysis of post-translational modifications', Nat. Biotechnol., Vol. 21, pp. 255-261.
11. Figeys, D. (2004), 'Combining different 'omics' technologies to map and validate protein-protein interactions in humans', Brief. Funct. Genomic. Proteomic., Vol. 2, pp. 357-365.
12. Russell, R. B., Alber, F., Aloy, P. et al. (2004), 'A structural perspective on protein-protein interactions', Curr. Opin. Struct. Biol., Vol. 14, pp. 313-324.
13. Grant, S. G. and Husi, H. (2001), 'Proteomics of multiprotein complexes: Answering fundamental questions in neuroscience', Trends Biotechnol., Vol. 19, pp. S49-S54.
14. Aggarwal, B. B. (2003), 'Signalling pathways of the TNF superfamily: A double-edged sword', Nat. Rev. Immunol., Vol. 3, pp. 745-756.
15. Anderson, N. L. and Anderson, N. G. (2002), 'The human plasma proteome: History, character, and diagnostic prospects', Mol. Cell. Proteomics, Vol. 1, pp. 845-867.
16. Holly, J. (2004), 'Physiology of the IGF system', Novartis Found. Symp., Vol. 262, pp. 19-26; Discussion 26-35, 265-268.
17. Figeys, D., McBroom, L. D. and Moran, M. F. (2001), 'Mass spectrometry for the study of protein-protein interactions', Methods, Vol. 24, pp. 230-239.
18. Nair, K. S., Jaleel, A., Asmann, Y. W. et al. (2004), 'Proteomic research: Potential opportunities for clinical and physiological investigators', Am. J. Physiol. Endocrinol. Metab., Vol. 286, pp. E863-E874.
19. Arthur, J. M. (2003), 'Proteomics', Curr. Opin. Nephrol. Hypertens., Vol. 12, pp. 423-430.
20. Hanash, S. (2003), 'Disease proteomics', Nature, Vol. 422, pp. 226-232.
21. Clack, J. W., Juhl, M., Rice, C. A. et al. (2003), 'Proteomic analysis of transducin beta-subunit structural heterogeneity', Electrophoresis, Vol. 24, pp. 3493-3499.
22. Packer, N. H. and Harrison, M. J. (1998), 'Glycobiology and proteomics: Is mass spectrometry the Holy Grail?', Electrophoresis, Vol. 19, pp. 1872-1882.
23. Lal, S. P., Christopherson, R. I. and dos Remedios, C. G. (2002), 'Antibody arrays: An embryonic but rapidly growing technology', Drug Discov. Today, Vol. 7, pp. S143-S149.
24. Burgess, R. R. and Thompson, N. E. (2002), 'Advances in gentle immunoaffinity chromatography', Curr. Opin. Biotechnol., Vol. 13, pp. 304-308.
25. Hage, D. S. (1999), 'Affinity chromatography: A review of clinical applications', Clin. Chem., Vol. 45, pp. 593-615.
26. Clarke, N. J., Crow, F. W., Younkin, S. and Naylor, S. (2001), 'Analysis of in vivo-derived amyloid-beta polypeptides by on-line two-dimensional chromatography-mass spectrometry', Anal. Biochem., Vol. 298, pp. 32-39.
27. Kiernan, U. A., Tubbs, K. A., Nedelkov, D. et al. (2003), 'Comparative urine protein phenotyping using mass spectrometric immunoassay', J. Proteome Res., Vol. 2, pp. 191-197.
28. Lim, A., Sengupta, S., McComb, M. E. et al. (2003), ' In vitro and in vivo interactions of homocysteine with human plasma transthyretin', J. Biol. Chem., Vol. 278, pp. 49707-49713.
29. Nedelkov, D., Tubbs, K. A., Niederkofler, E. E. et al. (2004), 'High-throughput comprehensive analysis of human plasma proteins: A step toward population proteomics', Anal. Chem., Vol. 76, pp. 1733-1737.
30. Tubbs, K. A., Nedelkov, D. and Nelson, R. W. (2001), 'Detection and quantification of beta-2-microglobulin using mass spectrometric immunoassay', Anal. Biochem., Vol. 289, pp. 26-35.
31. Sydor, J. R., Scalf, M., Sideris, S. et al. (2003), 'Chip-based analysis of protein-protein interactions by fluorescence detection and on-chip immunoprecipitation combined with microLC-MS/MS analysis', Anal. Chem., Vol. 75, pp. 6163-6170.
32. Lin, Z., Crockett, D. K., Lim, M. S. and Elenitoba-Johnson, K. S. (2003),'High-throughput analysis of protein/peptide complexes by immunoprecipitation and automated LC-MS/MS', J. Biomol. Tech., Vol. 14, pp. 149-155.
33. Davies, H., Lomas, L. and Austen, B. (1999), 'Profiling of amyloid beta peptide variants using SELDI protein chip arrays', Biotechniques, Vol. 27, pp. 1258-1261.
34. Tolson, J., Bogumil, R., Brunst, E. et al. (2004), 'Serum protein profiling by SELDI mass spectrometry: Detection of multiple variants of serum amyloid alpha in renal cancer patients', Lab. Invest., Vol. 84, pp. 845-856.
35. Nelson, R. W., Nedelkov, D. and Tubbs, K. A. (2000), 'Biomolecular Interaction Analysis Mass Spectometry. BIA/MS can detect and characterize proteins in complex biological fluids at the low- to subfemtomole level', Anal. Chem., Vol. 72, pp. 404A-411A.
36. Nelson, R. W., Nedelkov, D. and Tubbs, K. A. (2000), 'Biosensor chip mass spectrometry: A chip-based proteomics approach', Electrophoresis, Vol. 21, pp. 1155-1163.
37. Anahory, T., Dechaud, H., Bennes, R. et al. (2002), 'Identification of new proteins in follicular fluid of mature human follicles', Electrophoresis, Vol. 23, pp. 1197-1202.
38. Glokler, J. and Angenendt, P. (2003), 'Protein and antibody microarray technology', J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., Vol. 797, pp. 229-240.
39. Zhu, H. and Snyder, M. (2003), 'Protein chip technology', Curr. Opin. Chem. Biol., Vol. 7, pp. 55-63.
40. Rappsilber, J. and Mann, M. (2002), 'What does it mean to identify a protein in proteomics?', Trends Biochem. Sci., Vol. 27, pp. 74-78.
41. Haab, B. B. (2001), 'Advances in protein microarray technology for protein expression and interaction profiling', Curr. Opin. Drug Discov. Devel., Vol. 4, pp. 116-123.
42. MacBeath, G. (2002), 'Protein microarrays and proteomics', Nat. Genet., Vol. 32, pp. 526-532.
43. Ingenbleek, Y. and Young, V. (1994), 'Transthyretin (prealbumin) in health and disease: Nutritional implications', Annu. Rev. Nutr., Vol. 14, pp. 495-533.
44. Power, D. M., Elias, N. P., Richardson, S. J. et al. (2000), 'Evolution of the thyroid hormone-binding protein, transthyretin', Gen. Comp. Endocrinol., Vol. 119, pp. 241-255.
45. Schreiber, G. (2002), 'The evolutionary and integrative roles of transthyretin in thyroid hormone homeostasis', J. Endocrinol., Vol. 175, pp. 61-73.
46. Gaetani, S., Bellovino, D., Apreda, M. and Devirgiliis, C. (2002), 'Hepatic synthesis, maturation and complex formation between retinol-binding protein and transthyretin', Clin. Chem. Lab. Med., Vol. 40, pp. 1211-1220.
47. Monaco, H. L. (2000), 'The transthyretin-retinol-binding protein complex', Biochim. Biophys. Acta, Vol. 1482, pp. 65-72.
48. Schweigert, F. J., Wirth, K. and Raila, J. (2004), 'Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay', Proteome Sci., Vol. 2, p. 5.
49. Sousa, M. M., Norden, A. G., Jacobsen, C. et al. (2000), 'Evidence for the role of megalin in renal uptake of transthyretin', J. Biol. Chem., Vol. 275, pp. 38176-38181.
50. Quan, D. and Cohen, J. A. (2002), 'Clinical variant of familial amyloid polyneuropathy', Muscle Nerve, Vol. 26, pp. 417-420.
51. Takaoka, Y., Ohta, M., Miyakawa, K. et al. (2004), 'Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met', Am. J. Pathol., Vol. 164, pp. 337-345.
52. Lim, A., Prokaeva, T., McComb, M. E. et al. (2002), 'Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis', Anal. Chem., Vol. 74, pp. 741-751.
53. Damas, A. M. and Saraiva, M. J. (2000), 'Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies', J. Struct. Biol., Vol. 130, pp. 290-299.
54. Merlini, G. and Bellotti, V. (2003), 'Molecular mechanisms of amyloidosis', N. Engl. J. Med., Vol. 349, pp. 583-596.
55. Zhang, Q. and Kelly, J. W. (2003), 'Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions', Biochemistry, Vol. 42, pp. 8756-8761.
56. Sass, J. O., Nakanishi, T., Sato, T. et al. (2003), 'S-homocysteinylation of transthyretin is detected in plasma and serum of humans with different types of hyperhomocysteinemia', Biochem. Biophys. Res. Commun., Vol. 310, pp. 242-246.
57. Zhang, Z., Bast, Jr., R. C., Yu, Y. et al. (2004), 'Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer', Cancer Res., Vol. 64, pp. 5882-5890.
58. Waits, R. P., Yamada, T., Uemichi, T. and Benson, M. D. (1995), 'Low plasma concentrations of retinol-binding protein in individuals with mutations affecting position 84 of the transthyretin molecule', Clin. Chem., Vol. 41, pp. 1288-1291.
59. Caputo, E., Moharram, R. and Martin, B. M. (2003), 'Methods for on-chip protein analysis', Anal. Biochem., Vol. 321, pp. 116-124.
60. Lin, S., Tornatore, P., King, D. et al. (2001), 'Limited acid hydrolysis as a means of fragmenting proteins isolated upon ProteinChip array surfaces', Proteomics, Vol. 1, pp. 1172-1184.
61. Nakanishi, T., Sato, T., Sakoda, S. et al. (2004), 'Modification of cysteine residue in transthyretin and a synthetic peptide: Analyses by electrospray ionization mass spectrometry', Biochim. Biophys. Acta, Vol. 1698, pp. 45-53.
62. Nedelkov, D. and Nelson, R. W. (2003), 'Delineating protein-protein interactions via biomolecular interaction analysis-mass spectrometry', J. Mol. Recognit., Vol. 16, pp. 9-14.